Original Research ArticleInternational Journal of Pharmaceutical InvestigationVol. 6 | Issue 3 | 2016 | pp. 158–168Open access
Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns
- 1,
- 1,
- 1,
- 1,
- 1,
- 2*
- 1 Department of Pharmaceutics, Anand Pharmacy College, Anand.
- 2 Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, Gujarat, India.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Nirav Patel
Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, Gujarat, India.
Email: nirav2564@gmail.com
Copyright: © 2016 Manuscript Technomedia. This is an open access article.
- Published:
- Aug 1, 2016
How to cite
Thakkar, V., Korat, V., Baldaniya, L., Gohel, M., Gandhi, T., & Patel, N. (2016). Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns. International Journal of Pharmaceutical Investigation, 6(3), 158–168. https://doi.org/10.4103/2230-973X.187343
Abstract
Introduction: The aim of burn management and therapy is fast healing and epithelisation to prevent infection. The present study is concerned with the development and characterization of a novel nanaoparticulate system; cubosomes, loaded with silver sulfadiazine (SSD) and Aloe vera for topical treatment of infected burns. Methods: Cubosome dispersions were formulated by an emulsification technique using different concentrations of a lipid phase Glyceryl Monooleate (GMO) and Poloxamer 407. The optimum formulae were incorporated in an aloe vera gel containing carbopol 934, to form cubosomal hydrogels (cubogels). The cubogels were characterized by in vitro release of SSD, rheological properties, pH, bioadhesion, Transmission Electron Microscopy and in-vivo Wound Healing Study. Results: The results show that the different concentration of GMO had significant effect on particle size, % EE and in vitro drug release. From the in-vitro drug release pattern and similarity factor (f2), it was concluded that batch CG3 (15% GMO and 1% P407) exhibited complete and controlled drug release within 12 hour (i.e. 98.25%), better bio adhesion and superior burn healing as compared to the marketed product. Conclusion: The in vivo burns healing study in rats revealed that the prepared optimized cubogel containing SSD and aloe vera has superior burns healing rate than cubogel with only SSD and marketed preparation so, it may be successfully used in the treatment of deep second degree burn.
Keywords
Subject
Article metadata
| Title | Development and characterization of novel hydrogel containing antimicrobial drug for treatment of burns |
|---|---|
| Authors | Vaishali Thakkar; Vaishali Korat; Lalji Baldaniya; Mukesh Gohel; Tejal Gandhi; Nirav Patel |
| Affiliations | Department of Pharmaceutics, Anand Pharmacy College, Anand.; Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, Gujarat, India. |
| Corresponding author | nirav2564@gmail.com |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 6, Issue 3 (2016) |
Also in this issue
- Pharmaceutical product development: A quality by design approachpp. 129–138
- Improved dissolution and anti-inflammatory activity of ibuprofen-polyethylene glycol 8000 solid dispersion systemspp. 139–147
- Preparation and evaluation of a novel oral delivery system for low molecular weight heparinpp. 148–157
- Preparation, characterization, and in vivo evaluation of valsartan porous matrices using emulsion solvent evaporation techniquepp. 169–179
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026